4.6 Review

Hemoglobin allostery and pharmacology

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Advances in Sickle Cell Disease Treatments

Aline Renata Pavan et al.

Summary: SCD is a genetic disorder affecting red blood cells with high morbidity and mortality, particularly in low income countries. Recent advancements in drug discovery have led to new therapeutic alternatives for patients, addressing the main symptoms of the disease and improving treatment options.

CURRENT MEDICINAL CHEMISTRY (2021)

Article Pharmacology & Pharmacy

Enarodustat: First Approval

Anthony Markham

Summary: Enarodustat, an orally active HIF-PH inhibitor, is being developed as an alternative to injectable erythropoiesis-stimulating agents for the treatment of anemia associated with CKD. Approved in Japan, the drug is currently undergoing clinical development in the USA and South Korea. This article outlines the key milestones in the development of enarodustat leading to its first approval for CKD-associated anemia.

DRUGS (2021)

Review Biochemistry & Molecular Biology

Ligand-Linked Association-Dissociation in Transport Proteins and Hormone Receptors

Fulvio Saccoccia et al.

CURRENT PROTEIN & PEPTIDE SCIENCE (2020)

Article Pharmacology & Pharmacy

Pharmacokinetics and pharmacodynamics of voxelotor (GBT440) in healthy adults and patients with sickle cell disease

Athiwat Hutchaleelaha et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)

Review Biochemistry & Molecular Biology

Allostery in Its Many Disguises: From Theory to Applications

Shoshana J. Wodak et al.

STRUCTURE (2019)

Review Biochemistry & Molecular Biology

On the Measurement of Cooperativity and the Physico-Chemical Meaning of the Hill Coefficient

Andrea Bellelli et al.

CURRENT PROTEIN & PEPTIDE SCIENCE (2019)

Article Urology & Nephrology

Biosimilar Erythropoiesis-Stimulating Agents in Chronic Kidney Disease

Hitesh H. Shah et al.

ADVANCES IN CHRONIC KIDNEY DISEASE (2019)

Review Pharmacology & Pharmacy

Pharmacologic Targeting of Hypoxia-Inducible Factors

Gregg L. Semenza

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 59 (2019)

Review Toxicology

A Review on Ingested Cyanide: Risks, Clinical Presentation, Diagnostics, and Treatment Challenges

Tara B. Hendry-Hofer et al.

JOURNAL OF MEDICAL TOXICOLOGY (2019)

Review Biochemistry & Molecular Biology

Non-Allosteric Cooperativity in Hemoglobin

Andrea Bellelli

CURRENT PROTEIN & PEPTIDE SCIENCE (2018)

Article Physiology

Methylene blue counteracts cyanide cardiotoxicity: cellular mechanisms

Joseph Y. Cheung et al.

JOURNAL OF APPLIED PHYSIOLOGY (2018)

Article Hematology

Apixaban Interacts with Haemoglobin: Effects on Its Plasma Levels

Monica Sacco et al.

THROMBOSIS AND HAEMOSTASIS (2018)

Article Biochemistry & Molecular Biology

Direct observation of conformational population shifts in crystalline human hemoglobin

Naoya Shibayama et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2017)

Review Hematology

Should modulation of p50 be a therapeutic target in the critically ill?

Amudan J. Srinivasan et al.

EXPERT REVIEW OF HEMATOLOGY (2017)

Article Biotechnology & Applied Microbiology

Current Standards of Care and Long Term Outcomes for Thalassemia and Sickle Cell Disease

Satheesh Chonat et al.

GENE AND CELL THERAPIES FOR BETA-GLOBINOPATHIES (2017)

Article Biochemistry & Molecular Biology

Identification of a Small Molecule that Increases Hemoglobin Oxygen Affinity and Reduces SS Erythrocyte Sickling

Akito Nakagawa et al.

ACS CHEMICAL BIOLOGY (2014)

Review Biochemistry & Molecular Biology

Development of Recombinant Hemoglobin-Based Oxygen Carriers

Cornelius L. Varnado et al.

ANTIOXIDANTS & REDOX SIGNALING (2013)

Review Biochemistry & Molecular Biology

Hemoglobin allostery: Variations on the theme

Andrea Bellelli et al.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2011)

Review Biochemistry & Molecular Biology

Hemoglobin and Cooperativity: Experiments and Theories

Andrea Bellelli

CURRENT PROTEIN & PEPTIDE SCIENCE (2010)

Article Cardiac & Cardiovascular Systems

Reduction in hemoglobin-oxygen affinity results in the improvement of exercise capacity in mice with chronic heart failure

Tetsuya Watanabe et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)

Article Physiology

The role of hemoglobin oxygen affinity in oxygen transport at high altitude

Robert M. Winslow

RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2007)

Article Biochemistry & Molecular Biology

Binding modes of L35 to α- and β-semihemoglobins:: Structural insights into the inequivalence of α- and β-subunits of hemoglobin

M. Cristina De Rosa et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)

Review Hematology

New agents that stimulate erythropoiesis

H. Franklin Bunn

BLOOD (2007)

Article Biochemistry & Molecular Biology

1.25 Å resolution crystal structures of human haemoglobin in the oxy, deoxy and carbonmonoxy forms

Sam-Yong Park et al.

JOURNAL OF MOLECULAR BIOLOGY (2006)

Article Multidisciplinary Sciences

Phylogenetic comparisons suggest that distance from the locus control region guides developmental expression of primate β-type globin genes

RM Johnson et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Review Biochemistry & Molecular Biology

The allosteric properties of hemoglobin: Insights from natural and site directed mutants

A Bellelli et al.

CURRENT PROTEIN & PEPTIDE SCIENCE (2006)

Review Biochemistry & Molecular Biology

S-Nitrosohemoglobin: An allosteric mediator of no group function in mammalian vasculature

EJ Frehm et al.

FREE RADICAL BIOLOGY AND MEDICINE (2004)

Article Cardiac & Cardiovascular Systems

Increasing P50 does not improve DO2 CRIT or systemic Vo2 in severe anemia

O Eichelbrönner et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)

Review Biochemistry & Molecular Biology

Cooperative hemoglobins: conserved fold, diverse quaternary assemblies and allosteric mechanisms

WE Royer et al.

TRENDS IN BIOCHEMICAL SCIENCES (2001)